Daily46m
FDA Approves Esketamine Nasal Spray for Treatment-Resistant Depression
The FDA has approved esketamine (Spravato) nasal spray as a monotherapy for adults with treatment-resistant depression. This ...
Hosted on MSN17m
FDA Clears Spravato For Monotherapy Depression Treatments
The Food and Drug Administration has approved Johnson & Johnson's nasal spray as a standalone treatment for severe forms of ...
New Nasal Spray to Treat Depression Gets FDA Approval
The U.S. Food and Drug Administration has approved a nasal spray to treat depression—the first-ever stand-alone medication for patients with severe depression. Johnson & Johnson said patients who use ...
L.A.’s Record-Breaking 262-Day Dry Spell Is Finally Ending
The historic dry spell that fueled the devastating Los Angeles wildfires is expected to end this weekend. Forecasters expect light rain and mountain snow on Saturday, ending 262 days and counting ...